Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.
Authors:
- T G WoodworthTWT G Woodworth
- D E FurstDFD E Furst
- V StrandVSV Strand
- J KempeniJKJ Kempeni
- H FennerHFH Fenner
- C S LauCLC S Lau
- F MillerFMF Miller
- R DayRDR Day
- J LipaniJLJ Lipani
- P BrooksPBP Brooks
- 1 May 2001
- journal article
- review article
- Vol. 28 (5) , 1163-9